1. Home
  2. CBUS vs MYO Comparison

CBUS vs MYO Comparison

Compare CBUS & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cibus Inc.

CBUS

Cibus Inc.

HOLD

Current Price

$1.65

Market Cap

69.9M

Sector

Industrials

ML Signal

HOLD

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$1.01

Market Cap

33.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBUS
MYO
Founded
2010
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Industrial Specialties
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.9M
33.2M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
CBUS
MYO
Price
$1.65
$1.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$20.00
$7.67
AVG Volume (30 Days)
172.4K
762.9K
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,794,000.00
$41,643,203.00
Revenue This Year
N/A
$24.07
Revenue Next Year
$109.96
$17.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
65.00
52 Week Low
$1.09
$0.71
52 Week High
$3.40
$7.17

Technical Indicators

Market Signals
Indicator
CBUS
MYO
Relative Strength Index (RSI) 57.70 55.49
Support Level $1.60 $0.91
Resistance Level $1.77 $1.05
Average True Range (ATR) 0.14 0.08
MACD 0.01 -0.00
Stochastic Oscillator 63.64 52.17

Price Performance

Historical Comparison
CBUS
MYO

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: